(IN BRIEF) Evotec SE has announced that Esperion Therapeutics has nominated an oral preclinical development candidate for primary sclerosing cholangitis (PSC), marking a major milestone in their collaboration. The PDC, developed through Evotec’s integrated small molecule discovery platform and Esperion’s … Read the full press release
Posted in Business, Germany, Government, Healthcare, News, Pharma & Biotech, Science, Technology
Tagged ACLY biology, bile ducts, clinical development, collaboration, Cord Dohrmann, drug discovery, Esperion Therapeutics, Evotec Advances Collaboration with Esperion as New ACLY-Based Candidate Targets Primary Sclerosing Cholangitis, Evotec and Esperion Advance Novel Treatment Candidate for Primary Sclerosing Cholangitis, Evotec INDiGO, Evotec SE, fibrosis, Frankfurt Stock Exchange EVT, hepatology, IND-enabling platform, liver disease, milestone payment, NASDAQ ESPR, NASDAQ EVO, preclinical development candidate, primary sclerosing cholangitis, PSC, rare diseases
(IN BRIEF) GSK’s Shingrix vaccine has been approved by China’s NMPA for adults aged 18 and over who are immunocompromised or immunosuppressed, marking the first shingles vaccine available for this group in the country. Affecting about six million people annually … Read the full press release
Posted in Business, Healthcare, Investment, Pharma & Biotech, Science, Technology, United Kingdom
Tagged CHINA, China National Medical Products Administration, clinical studies, global health, GSK, GSK Expands Shingrix Approval in China to Include Immunocompromised Adults at Risk of Shingles, GSK Strengthens Vaccine Portfolio with Shingrix Approval for High-Risk Adult Populations in China, GSK Wins China Approval for Shingrix in Immunocompromised Adults Expanding Protection Against Shingles, Healthcare, herpes zoster, immunocompromised adults, immunodeficiency, immunosuppression, infectious diseases, NMPA, preventive medicine, public health, Recombinant Zoster Vaccine, RZV, Sanjay Gurunathan, Shingles, Shingrix, vaccine approval, Vaccine Innovation
(IN BRIEF) Accenture has acquired Decho, a UK-based Palantir and AI consultancy, to expand its data and AI capabilities and strengthen its delivery of Palantir-powered solutions across health, government, defense, and commercial sectors. Decho, a Palantir strategic alliance partner, specializes … Read the full press release
Posted in Artificial Intelligence (AI), Business, Defence, Government, Healthcare, Industrial, Investment, Ireland, Management, News, Technology, United Kingdom
Tagged Accenture, Accenture Acquires Decho to Advance Palantir-Based AI Solutions Across Public and Private Sectors, Accenture Acquires Decho to Strengthen Palantir and AI Capabilities Across UK and Global Markets, Accenture Expands Data and AI Capabilities with Acquisition of UK-Based Palantir Specialist Decho, acquisition, acquisitions, Advanced Engineering, AI consultancy, AI Integration, AIP, analytics, Anna Davies, artificial intelligence, Artificial Intelligence Platform, Bryan Rich, data transformation, Decho, Defense, digital, digital transformation, enterprise data, generative AI, Healthcare, innovation strategy, Palantir, Palantir alliance, Palantir Foundry, public sector, software, technology, UK technology
(IN BRIEF) The Lichen Sclerosus Guide, co-produced by the University of Bristol, University of Nottingham, and NHS partners, has won the 2025 Picker Experience Network Award for excellence in patient communication. The online guide provides vital information and support for … Read the full press release
Posted in Awards, Education, Healthcare, News, Science, Society, Technology, United Kingdom
Tagged Award-Winning Online Guide Helps Break Stigma and Support People Living with Vulval Lichen Sclerosus, Bristol Medical School, Caroline Owen, co-produced research, Dermatology, East Lancashire Hospitals NHS Trust, health literacy, Lichen Sclerosus Guide, NHS, Nottingham University Hospitals NHS Trust, online resource, patient communication, patient empowerment, PEN Awards 2025, Picker Experience Network Awards, public health, Sophie Rees, University of Bristol, University of Bristol and NHS Collaboration Wins National Recognition for Improving Lichen Sclerosus Care, University of Bristol’s Lichen Sclerosus Guide Wins Top National Award for Patient Empowerment, University of Nottingham, vulval lichen sclerosus, Women’s Health
(IN BRIEF) Researchers at the University of Bristol have developed a promising new gene therapy that could help prevent diabetic kidney disease in people with type 1 diabetes. The treatment uses a harmless virus to deliver the VEGF-C protein directly … Read the full press release
Posted in Education, Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged albuminuria, Aldara Martin Alonso, American Diabetes Association, biomedical research, Bristol Medical School, Chronic kidney disease, diabetes complications, Diabetes UK, Diabetes UK and University of Bristol Study Finds Gene Therapy Could Halt Kidney Disease Progression, diabetic kidney disease, Faye Riley, gene therapy, glomerulus, kidney health, Molecular Therapy, Rebecca Foster, Translational Health Sciences, type 1 diabetes, University of Bristol, University of Bristol Researchers Pioneer New Gene-Based Treatment for Diabetic Kidney Damage, University of Bristol Unveils Gene Therapy Breakthrough to Prevent Kidney Disease in Type 1 Diabetes, VEGF-C
(IN BRIEF) The European Investment Bank and European Commission are jointly supporting BioNTech’s mRNA manufacturing facility in Kigali, Rwanda, with up to €95 million in blended financing. The project aims to strengthen Africa’s capacity to produce vaccines locally for diseases … Read the full press release
Posted in Banks, European Union, Financial, Healthcare, Investment, Luxembourg, News, Pharma & Biotech, Technology
Tagged Africa CDC, African Union, and CEPI Join Forces to Strengthen Africa’s Vaccine Independence Through BioNTech’s Kigali mRNA Facility, BioNTech, BioNTech Secures up to €95 Million in EU and EIB Financing to Boost Vaccine Manufacturing Capacity in Kigali, biotechnology, CEPI, Dr Amadou Sall, EIB, EU, European Commission, European Investment Bank, Global Gateway, HIV, Jozef Sikela, Karl Nehammer, Kigali, local production, malaria, mpox, mRNA Vaccines, public health, Rwanda, Sierk Poetting, Sustainable Healthcare, Team Europe, tuberculosis, Vaccine Innovation, vaccine manufacturing
(IN BRIEF) The LEGO Group has reached a major milestone with over one million children worldwide benefiting from its LEGO MRI Scanner set—a hands-on educational model designed to help young patients feel more comfortable during MRI procedures. Developed in collaboration … Read the full press release
Posted in Denmark, Entertainment, Environment, Healthcare, Society
Tagged Aarhus University Hospital, child-centered care, children’s wellbeing, Denmark, Diana Ringe Krogh, From Scan to Smiles, global philanthropy, Healthcare Innovation, hospitals, Ivy, Jannie Bøge Steinmeier Larsen, Kaiser Permanente, learning through play, LEGO Foundation, LEGO Group, LEGO Group’s MRI Scanner Set Helps Over One Million Children Feel Calm and Confident During Hospital Scans, LEGO Group’s MRI Scanner Set Helps Over One Million Children Feel Calm and Prepared for Medical Scans, medical play, MRI Scanner set, pediatric care, Rachel, Royal Hospital for Children and Young People Edinburgh, sedation reduction, social responsibility, Traci Aoki-Tan, Zero-Emission Transport
(IN BRIEF) Marks & Spencer (M&S) has revealed that retail is the leading first employer for young people in the UK, with one in four starting their careers in the industry. The company’s Marks & Start programme, developed with The … Read the full press release
(IN BRIEF) The International Federation of Gynecology and Obstetrics (FIGO) has selected Montréal, Canada, as the host city for the XXVI FIGO World Congress of Gynecology and Obstetrics, scheduled for 31 October–5 November 2027. Organised in partnership with the Society … Read the full press release
Posted in Healthcare, Management, News, Science, Society, United Kingdom
Tagged advocacy, CANADA, Clinicians, Diane Francoeur, FIGO, FIGO and SOGC Announce Montréal as Venue for 2027 Congress on Gynecology and Obstetrics, FIGO and SOGC to Host the 2027 World Congress of Gynecology and Obstetrics in Montréal, FIGO World Congress 2027, FIGO World Congress 2027 Heads to Montréal, Frank Louwen, global health, gynecology, Healthcare, inclusivity, INNOVATION, international collaboration, International Federation of Gynecology and Obstetrics, medical conference, Montréal, Montréal Selected as Host City for FIGO World Congress 2027 in Partnership with SOGC, Obstetrics, Palais des congrès de Montréal, policymakers, RESEARCH, scientific programme, Showcasing Global Leadership in Women’s Health, Society of Obstetricians and Gynaecologists of Canada, SOGC, sustainability, Women’s Health
(IN BRIEF) Siemens Smart Infrastructure has implemented its Building X platform at San Juan de Dios Hospital in Seville, Spain, making the facility a model for smart and sustainable healthcare operations. The AI-powered system integrates energy management, security, and HVAC … Read the full press release
Posted in Energy, Gas & Oil, Environment, Germany, Healthcare, Industrial, Infrastructure & Utilities, News, Spain, Technology, Transportation & Logistics
Tagged AI-based platform, Building Management System, Building X, carbon reduction, Delphine Clément, Desigo CC, digital building, energy efficiency, Energy Manager, facility optimization, healthcare digitalization, HVAC automation, María Jesús Pareja, Operations Manager, San Juan de Dios Hospital, security management, Seville, Siemens, Siemens Enables 35% Operational Cost Reduction at Spanish Hospital through Digital Building Integration, Siemens Partners with San Juan de Dios Hospital to Lead the Next Generation of Smart Healthcare Buildings, Siemens Smart Infrastructure, Siemens Transforms San Juan de Dios Hospital into a Smart, Siemens Xcelerator, Siveillance Suite, Smart Hospital, Spain, sustainability, Sustainable Facility with Building X
(IN BRIEF) A new study led by researchers at The Institute of Cancer Research, London, has identified a promising new combination therapy for pancreatic cancer that could transform future treatment. The dual approach — combining boiling histotripsy and oncolytic reovirus … Read the full press release
Posted in Business, Education, Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged boiling histotripsy, cancer research, cancer treatment innovation, Gail ter Haar, ICR, ICR study identifies new immune-based combination strategy to improve pancreatic cancer treatment outcomes, immune response, immunotherapy, Institute of Cancer Research, macrophages, neutrophils, oncolytic reovirus, pancreatic cancer, Pancreatic cancer study from ICR highlights new dual treatment approach and reveals key immune cell insights, Pancreatic Cancer UK, Petros Mouratidis, Pharmaceutics, preclinical study, The Institute of Cancer Research identifies promising dual treatment strategy for pancreatic cancer, tumour microenvironment, ultrasound therapy, viral immunotherapy
(IN BRIEF) The Institute of Cancer Research has renewed its Athena Swan Silver Award for 2025–2029, recognising continued progress in promoting gender equality and fostering an inclusive workplace. The award highlights key achievements such as improved recruitment and flexible working … Read the full press release
Posted in Business, Education, Healthcare, Management, News, Pharma & Biotech, Science, Society, Technology, United Kingdom
Tagged academic leadership, Advance HE, Alan Cumber, and research culture, Athena Swan action plan, Athena Swan Silver Award, career development, diversity, Diversity And Inclusion, Dr Barbara Pittam, equity in research, flexible working, gender equality, Gender Pay Gap, higher education, ICR, ICR recognised for advancing inclusive excellence with Athena Swan Silver Award renewal through 2029, ICR secures four-year Athena Swan Silver Award recognising progress in equity, Institute of Cancer Research, Institute of Cancer Research celebrates renewed Athena Swan Silver Award with new gender equality action plan, Pathway to Independence program, Professor Christina Yap, Professor Kristian Helin, research culture, Technician Career Pathways
Europe’s RNA immunotherapy sector is gaining speed with new in vivo CAR-T and mRNA vaccine trials. Germany approved the region’s first in vivo CAR-T study, marking regulatory progress. The UK’s Cancer Vaccine Launch Pad advances personalised mRNA cancer vaccine trials … Read the full press release
Posted in Belgium, Business, Germany, Healthcare, Pharma & Biotech, Science, Technology, United Kingdom
Tagged AstraZeneca, ATMP, autoimmunity, BioNTech, BioNTech’s BNT116, biotechnology, Cancer Vaccine Launch Pad, CAR-T therapy, clinical trials, CREATE Medicines, CureVac, EMA, EU-FAB, Europe, Europe Becomes a Hub for Next-Generation RNA Immunotherapy with Strong Clinical and Industrial Momentum, Europe’s Biotech Sector Accelerates RNA-Based Immunotherapy with Breakthroughs in CAR-T and mRNA Vaccines, Europe’s RNA Immunotherapy Industry Poised for Expansion as BioNTech AstraZeneca and CREATE Medicines Lead Advances, Europe’s RNA Immunotherapy Landscape Expands with First In Vivo CAR-T Trial and Growing mRNA Vaccine Efforts, Europe’s RNA Immunotherapy Pipeline Gains Scale as Regulators and Industry Push for Next-Gen Cancer Treatments, fibrosis, Germany, Imfinzi, immuno-oncology, in vivo CAR-T, INT2104, mRNA Vaccines, multi-lineage immune programming, Myeloid Therapeutics, NHS England, oncology, pharma, RNA immunotherapy, RNA Immunotherapy in Europe: Emerging Trials Strategic Mergers and a Clearer Regulatory Path, RNA Immunotherapy Takes Hold in Europe as BioNTech-CureVac Deal and CREATE Medicines Expansion Signal Maturity, RNA therapeutics, RNA-based therapies, United Kingdom
Rebrand: Myeloid Therapeutics becomes CREATE Medicines, reflecting a shift to multi-lineage RNA immune programming. Scientific Focus: Expanding beyond myeloid cells to include T and NK cells for scalable, redosable in vivo CAR therapies. Clinical Data: Over 40 patients treated with … Read the full press release
Posted in Business, Healthcare, Pharma & Biotech, Science, Technology
Tagged 8VC, ARCH Venture Partners, autoimmunity, B-cell depletion, biopsies, Biotech, biotechnology, breast cancer, cancer therapy, CAR+ immune cells, CD8 T cell recruitment, clinical trials, CREATE Medicines, CREATE Medicines Bridges Science Strategy and Investment with Expanded RNA Platform for In Vivo Multi-Immune Therapies in Europe and Beyond, CREATE Medicines Integrates Scientific Progress and Investor Backing to Lead Multi-Lineage RNA Immunotherapy’s Next Chapter in Europe, CREATE Medicines Rebrand Reflects Strategic Expansion into Multi-Lineage RNA Immunotherapy as Europe’s Biotech Sector Embraces In Vivo Therapies, CREATE Medicines Reinforces Its Market and Research Focus Through RNA-Driven Multi-Lineage Immune Programming Amid Rising European Investment in mRNA Therapeutics, CREATE Medicines Strengthens Its Scientific and Strategic Position with Multi-Lineage RNA Platform and Investor Support Across a Growing European Biotech Market, CREATE Medicines’ New Identity Combines RNA-Based Scientific Leadership and Investor Momentum with Expanding Opportunities in European Immunotherapy Markets, CREATE Medicines’ Transition Marks New Phase in RNA Immunotherapy Development and Strategic Growth in Europe’s Expanding Biotech Landscape, Daniel Getts, Daniel Getts Ph.D., fibrosis, Following Its Rebrand, From Myeloid Therapeutics to CREATE Medicines: A Rebrand Uniting RNA Innovation Investor Confidence and Expanding European Immunotherapy Ambitions, GPC3, GPC3-positive solid tumors, GPC3; hepatocellular carcinoma, Hatteras Venture Partners, HER2, HER2 multi-immune CAR, HER2; solid tumors, himeric antigen receptor, immune cell reprogramming, immune cells, immune remodeling, immunotherapies, immunotherapy, in vivo CAR, in vivo CAR-T mediated B cell depletion, in vivo multi-immune programming, mRNA, mRNA-LNP platform, MT-302, MT-303, MT-304, multi-immune programming, multilineage immune programming, myeloid, myeloid cells, Myeloid Therapeutics, myeloid-focused in vivo programming, Newpath Partners, NK cell programming, NK cells, off-the-shelf therapies, oncology, Phase 1 studies, Rebranded CREATE Medicines Aligns Scientific Innovation and Investor Backing to Advance RNA-Based In Vivo CAR Therapies in Global and European Markets, Rebranded CREATE Medicines Positions Itself at the Forefront of RNA Immunotherapy as Europe’s Biotech Ecosystem Accelerates Innovation, retrotransposon-based CAR-T, RNA retrotransposon, RNA technology, RNA-based in vivo CAR therapeutics, RNA-based therapeutics, solid tumors, T cells, therapies, TROP2, TROP2; solid tumors, tumors, vivo CAR, vivo CAR-T
(IN BRIEF) AstraZeneca reported positive Phase III Bax24 trial results showing that baxdrostat achieved a significant and clinically meaningful reduction in 24-hour ambulatory systolic blood pressure in patients with treatment-resistant hypertension. The once-daily oral therapy was well tolerated and maintained … Read the full press release
Posted in Business, Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Advancing Toward Regulatory Submission, AHA 2025, aldosterone, aldosterone synthase inhibitor, ambulatory blood pressure, American Heart Association, AstraZeneca, AstraZeneca’s Baxdrostat Achieves Significant Blood Pressure Reduction in Phase III Bax24 Trial, AstraZeneca’s Baxdrostat Achieves Strong Blood Pressure Reduction in Phase III Bax24 Trial for Resistant Hypertension, Bax24, Baxdrostat, Baxdrostat Delivers Significant 24-Hour Blood Pressure Control in Phase III Study, BaxHTN, Bryan Williams, cardiovascular health, Chronic kidney disease, clinical trial, heart failure prevention, Hypertension Treatment, Phase III results, primary aldosteronism, resistant hypertension, rHTN, SBP, Sharon Barr, systolic blood pressure
(IN BRIEF) FIGO has presented the 2025 FIGO Women’s Awards to nineteen exceptional women from around the world for their transformative contributions to gynaecology, obstetrics, and women’s health. The awards, announced during the FIGO General Assembly at the XXV FIGO … Read the full press release
Posted in Awards, Healthcare, Management, News, Science, Society, United Kingdom
Tagged Aisha Siddiqa, Amanda Black, Annettee Olivia Nakimuli, Cape Town, Cliona Murphy, Diana Ramašauskaitė, Elena Calle Texeira, Farhana Dewan, FIGO, FIGO Celebrates Excellence in Women’s Health with 2025 Awards Honouring Female Medical Innovators, FIGO General Assembly, FIGO Honours 19 Global Female Leaders with the 2025 Women’s Awards for Advancing Women’s Health, FIGO Women’s Awards 2025, FIGO Women’s Awards 2025 Highlight Global Leaders Shaping the Future of Obstetrics and Gynaecology, gender equality, global health, gynecology, Jackline Agel Akol, Jaideep Malhotra, Jane Hirst, Johanne Sundby, Kaori Koga, leadership, Linda Giudice, Liona Poon, Luz Marcela Celis Amórtegui, Ma. Corazon Zaida Gamilla, maternal health, Meliza Mejia, Obstetrics, reproductive health, Samia Ibrahim Esmeal, women in medicine, Women’s Health, XXV FIGO World Congress, Ya-Min Cheng
(IN BRIEF) The International Federation of Gynecology and Obstetrics (FIGO) has expanded its international network to 142 national societies with the inclusion of new members from Angola, Chad, and Guyana. These associations—Associação de Ginecologistas e Obstetras de Angola, Association Tchadienne … Read the full press release
Posted in Healthcare, Management, News, Science, Society, United Kingdom
Tagged Angola, Associação de Ginecologistas e Obstetras de Angola, Association Tchadienne des Gynécologues-Obstétriciens, Chad, Family Planning, FIGO, FIGO Grows to 142 National Societies with Addition of New Members Advancing Women’s Health Worldwide, FIGO membership, FIGO Welcomes New National Associations to Enhance Global Action for Women’s Health and Rights, Frank Louwen, gender equality, global health, Guyana, gynecology, healthcare access, International Federation of Gynecology and Obstetrics, maternal health, Obstetrics, reproductive health, The Guyana Obstetrics and Gynecology Society, women's rights, Women’s Health
(IN BRIEF) FIGO will host over 5,000 participants at the XXV FIGO World Congress of Gynecology and Obstetrics, held in Cape Town, South Africa, from 5–9 October 2025. Returning to Africa for the first time since 2009, the Congress will … Read the full press release
Posted in Awards, Healthcare, Management, News, Science, Society, United Kingdom
Tagged adolescent gynecology, Cape Town, climate change, endometriosis, FIGO, FIGO 2025 Congress Returns to Africa with Global Focus on Innovation Equity and Women’s Wellbeing, FIGO Film Festival, FIGO to Welcome Over 5000 Delegates to XXV World Congress in Cape Town to Advance Global Women’s Health, global health, gynecology, Health Equity, maternal health, menopause, migrant health, newborn health, Obstetrics, oncology, Over 5000 Health Leaders to Gather in Cape Town for FIGO 2025 to Champion Women’s and Girls’ Health, Professor Kihara Anne-Beatrice, Professor Paul Fogarty, reproductive health, reproductive rights, social justice, South Africa, SRHR, transgender care, Women’s Health, XXV FIGO World Congress
(IN BRIEF) At the XXIII FIGO World Congress of Gynecology and Obstetrics in Cape Town, six outstanding figures were honoured for their global impact on women’s health and rights. The FIGO Distinguished Merit Award was presented to Ethiopia’s Health Minister … Read the full press release
Posted in Awards, Healthcare, Management, News, Science, Society, United Kingdom
Tagged Afghanistan, Cape Town, Christine Solbach, ETHIOPIA, FIGO, FIGO World Congress in Cape Town Recognises Champions of Global Women’s Health and Empowerment, gender equality, Germany, global health, gynecology, health advocacy, HIV prevention, HPV vaccination, Japan, Jeannette Kagame, Linda-Gail Bekker, medical research, Mekdes Daba Feyssa, Obstetrics, reproductive health, Rwanda, Sima Samar, Six Global Leaders Honoured by FIGO for Outstanding Contributions to Women’s Health and Rights, South Africa, Tadashi Kimura, women's rights, Women’s Health, XXIII FIGO World Congress
CREATE Medicines (“CREATE”) broadens clinical programs and capabilities to expand therapeutic potential and improve patient outcomes Therapies tolerably program immune cells inside the human body, providing clear differentiation among competitors and significant value potential for all stakeholders CREATE Medicines will … Read the full press release
Posted in Business, Healthcare, Pharma & Biotech, Science, Technology
Tagged 8VC, ARCH Venture Partners, autoimmunity, B-cell depletion, biopsies, Biotech, biotechnology, breast cancer, cancer therapy, CAR+ immune cells, CD8 T cell recruitment, clinical trials, CREATE Medicines, Daniel Getts, Daniel Getts Ph.D., fibrosis, GPC3, GPC3-positive solid tumors, GPC3; hepatocellular carcinoma, Hatteras Venture Partners, HER2, HER2 multi-immune CAR, HER2; solid tumors, immune cell reprogramming, immune cells, immune remodeling, immunotherapies, immunotherapy, in vivo CAR, in vivo CAR-T mediated B cell depletion, in vivo multi-immune programming, mRNA, mRNA-LNP platform, MT-302, MT-303, MT-304, multi-immune programming, multilineage immune programming, myeloid, myeloid cells, Myeloid Therapeutics, myeloid-focused in vivo programming, Newpath Partners, NK cell programming, NK cells, off-the-shelf therapies, oncology, Phase 1 studies, retrotransposon-based CAR-T, RNA retrotransposon, RNA technology, RNA-based in vivo CAR therapeutics, RNA-based therapeutics, solid tumors, T cells, therapies, TROP2, TROP2; solid tumors, tumors, vivo CAR, vivo CAR-T
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?